In this interview from SLEEP 2023, Dayna Johnson, PhD, MPH, MSW, MS, addresses the various pathways through which cardiovascular health is adversely affected by suboptimal sleep health.
There are different pathways by which sleep contributes to cardiovascular disease, and these include hormone secretion, which connects to diabetes, and sympathetic nervous activity, which can increase blood pressure; sleep health is connected through these pathways to both traditional cardiovascular risk factors and total cardiovascular disease, explains Dayna Johnson, PhD, MPH, MSW, MS, assistant professor of epidemiology at the Rollins School of Public Health at Emory University in this interview from SLEEP 2023.
Transcript
How are poor sleep health and poor cardiovascular health interrelated?
We've seen a lot of progress in this area. In the last year, the American Heart Association has changed their platform, which was previously the Life’s Simple 7 to Life’s Essential 8—so really recognizing how important sleep is to cardiovascular health. So in the epidemiologic literature, we see that people who have a shorter sleep duration, poor sleep quality, they have a higher prevalence of hypertension, also diabetes, cardiovascular disease, and a higher rate of mortality.
There's different pathways by which sleep can contribute to cardiovascular disease. Some of the pathways include hormone secretion, so around insulin and glucose secretion, which connects to diabetes, which is associated with total cardiovascular disease. And then there's also pathways through the sympathetic nervous activity—which can lead to an increase in blood pressure—also is related to hypertension.
These different dimensions of sleep health are connected through these different pathways to traditional cardiovascular risk factors and to total cardiovascular disease.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More